Shelston IP congratulates Inventor Ernest Armstrong, and
entrepreneurs Matt Collett and Titus Day, on the highly successful
U.S. launch of Solar D, a ground-breaking sunscreen that protects
skin from the harmful UV rays of the sun while at the same time
allowing the natural production of vitamin D in the
Solar D sunscreen, developed and commercialised in
Australia, is an innovative new product that promises to
revolutionise the sun care market by finally allowing users to
properly protect themselves from harmful sun damage without
blocking the production of vitamin D.
Vitamin D, often referred to as the "sunshine
vitamin", is required for the absorption of calcium by the
body, and is therefore essential for strong bones, muscles and
general well-being. Vitamin D deficiency has been linked to
an increased risk of heart disease, diabetes and even
Through an evolutionary "quirk" cholesterol in
the skin is converted into vitamin D when it is exposed to UV rays
at particular wavelengths. While a small amount of vitamin D
can be absorbed by the body through foods and supplements, most
people get their quota by exposure to the sun's UV
However, despite Australians enjoying a warm climate and
an outdoor lifestyle with no shortage of sunshine, a study carried
out by scientists at the University of Melbourne and the Baker IDI
Heart & Diabetes Institute found that 31 per cent of
Australians are vitamin D deficient (results published in the
medical journal "Clinical Endocrinology"). It is
thought that increased skin cancer awareness and the widespread use
of broad spectrum sunscreens are partly responsible for this
vitamin D deficiency. Broad spectrum sunscreens are designed
to almost entirely block out UV rays and, in so doing, they prevent
the skin from absorbing the beneficial UV rays that allow us to
form vitamin D.
A vitamin D deficiency diagnosis is often met with a
recommendation for some SPF-free time in the sun – that's
not ideal if skin cancer is a concern! Luckily, Mr Armstrong,
a US-based inventor, and the makers of Solar D have delivered a
solution to this dilemma by producing a sunscreen that provides the
user with an SPF 50 rating of sun protection, whilst at the same
time allowing for vitamin D synthesis. The unique formulation
of sun screen agents is cleverly designed such that it selectively
permits UV rays to penetrate the skin at the particular wavelength
used by the body to synthesis vitamin D, while blocking out the UV
rays at the wavelengths that are responsible for the damaging
effects of the sun.
Solar D products have already taken Australia by
storm. They are stocked by a range of major retailers and
widely promoted by celebrities such as Sally Fitzgibbons, the NSW
Waratahs Super Rugby team, the BBL Sixers Cricket team and Jules
Sebastian. They are also available online at Amazon and Yves
Recently the New York Post reported on the benefits of
Solar D citing a study in which nearly 42 percent of US adults
showed insufficient vitamin D levels. The same study compared
Solar D to a commercial sunscreen with the same SPF and showed that
Solar D resulted in a significantly increased conversion of
cholesterol into vitamin D when exposed to UV rays. No
doubt Solar D has a bright future in the US market.
Shelston IP is pleased to have assisted Mr Armstrong and
Mr Day in obtaining patent protection for the Solar D product in
Australia, New Zealand and Japan and we look forward to obtaining
similar rights for this ground-breaking invention in the US,
Europe, Canada and Brazil.
The content of this article is intended to provide a
general guide to the subject matter. Specialist advice should be
sought about your specific circumstances.
Shelston IP ranked one of Australia's
leading Intellectual Property firms in 2015.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
The Ugg boots case revolves around who holds the trade mark rights to the word 'Ugg' in relation to sheepskin boots.
Some comments from our readers… “The articles are extremely timely and highly applicable” “I often find critical information not available elsewhere” “As in-house counsel, Mondaq’s service is of great value”
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).